NeuroAiD Safe Treatment Registry
NeuroAiD Safe Treatment Registry
The NeST registry is a pro-active industry-academic collaboration to assess the use and
 safety of NeuroAiD in the real world setting. An online entry system was set up to allow easy
 data entry and retrieval of clinical information.
The NeST Registry is designed as a product registry that would provide information on the use
 and safety of NeuroAiD in clinical practice. An online NeST Registry was set up to allow easy
 entry and retrieval of essential information including demographics, medical conditions,
 clinical assessments of neurological, functional, and cognitive state, compliance,
 concomitant medications and side effects if any, among patients on NeuroAiD. Participation is
 voluntary. Data collected are similar to information obtained during standard care and are
 prospectively entered by the participating physicians at baseline (before initialization of
 NeuroAiD) and during subsequent visits. The follow up visits are timed with clinical
 appointments. Anonymized data will be extracted and collectively analyzed. Initial target
 sample size for the registry is 2000.
Inclusion Criteria:

 -  Male or female

 -  Any age

 -  Taking, or has been prescribed NeuroAiD for any duration as judged by the physician
 and/or the participant

 -  Agrees to be included in the registry and allows retrieval and analysis of data in
 accordance with local requirements

 Exclusion Criteria:

 -  Unwillingness to participate

 -  Contraindication to NeuroAiD